Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons

Cell replacement therapy using embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is a promising strategy for the treatment of neurologic diseases such as Parkinson's disease (PD). However, a limiting factor for effective cell transplantation is the low survival rate of graf...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Tatsuya, Samata, Bumpei, Ogura, Aya, Miyamoto, Susumu, Takahashi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573719/
https://www.ncbi.nlm.nih.gov/pubmed/23423767
http://dx.doi.org/10.3389/fncel.2013.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573719/
https://www.ncbi.nlm.nih.gov/pubmed/23423767
http://dx.doi.org/10.3389/fncel.2013.00011

Ejemplares similares